Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.280
+0.020 (1.59%)
At close: Dec 19, 2025, 4:00 PM EST
1.320
+0.040 (3.13%)
After-hours: Dec 19, 2025, 5:35 PM EST
Marker Therapeutics Market Cap
Marker Therapeutics has a market cap or net worth of $21.34 million as of December 19, 2025. Its market cap has decreased by -30.48% in one year.
Market Cap
21.34M
Enterprise Value
3.42M
1-Year Change
-30.48%
Ranking
Category
Stock Price
$1.28
Market Cap Chart
Since November 8, 2016, Marker Therapeutics's market cap has decreased from $45.80M to $21.34M, a decrease of -53.40%. That is a compound annual growth rate of -8.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 18, 2025 | 21.00M | -24.46% |
| Dec 31, 2024 | 27.80M | -43.15% |
| Dec 29, 2023 | 48.90M | 120.27% |
| Dec 30, 2022 | 22.20M | -71.86% |
| Dec 31, 2021 | 78.90M | 13.36% |
| Dec 31, 2020 | 69.60M | -47.15% |
| Dec 31, 2019 | 131.70M | -47.70% |
| Dec 31, 2018 | 251.80M | 509.69% |
| Dec 29, 2017 | 41.30M | 27.08% |
| Dec 30, 2016 | 32.50M | -29.04% |
| Nov 8, 2016 | 45.80M | - |
View and export this data all the way back to 2016. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 943.99B |
| Johnson & Johnson | 504.27B |
| AbbVie | 395.31B |
| UnitedHealth Group | 302.73B |
| AstraZeneca | 281.22B |
| Novartis AG | 259.57B |
| Merck & Co. | 243.91B |
| Abbott Laboratories | 220.59B |